European Society for Organ Transplantation’s (ESOT) guidelines for desensitization treatment of highly sensitized kidney transplant patients published in Transplant International
· European guidelines target the management of highly sensitized kidney transplant patients (patients with human leukocyte antigen (HLA) antibodies) · These guidelines provide a new clinical practice tool for healthcare professionals to help achieve the best possible outcomes for highly sensitized kidney patients · Hansa Biopharma sponsors desensitization workstream as part of ESOT’s educational programs, via an educational grantLund, Sweden August 10, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today